10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)

424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)

8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)

8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)

EFFECT - Estrella Immunopharma, Inc. (0001844417) (Filer)

424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)

S-1/A - Estrella Immunopharma, Inc. (0001844417) (Filer)

10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)

NT 10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)

S-1/A - Estrella Immunopharma, Inc. (0001844417) (Filer)

Estrella to Begin Trading on NASDAQ Under the Ticker Symbols "ESLA" and "ESLAW" Beginning October 2, 2023 NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Estrella Immunopharma, Inc., formerly known as TradeUP Acquisition Corp. ("UPTD") (NASDAQ:UPTD, UPTDW, UPTDU))), today announced the successful closing of its business combination with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.  The resulting combined company will operate under the name Estrella Immunopharma, Inc. and will be led by Estrella Founder and CEO Dr. Cheng Liu. The com

NEW YORK, Sept. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from September 19, 2023 to October 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biop

NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from August 19, 2023 to September 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biophar

NEW YORK , July 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from July 19, 2023 to August 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma,

NEW YORK, July 12, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. ("TradeUP") (NASDAQ:UPTD), a publicly traded special purpose acquisition company, announced that it will hold a special meeting of stockholders of TradeUP on Monday, July 31, 2023 at 9:00 a.m. Eastern Time (the "Special Meeting") to vote on, among others, the proposed business combination (the "Merger") with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics. On September 30, 2022, the parties entered into a definitive business combination agreement (the "Business Combination Agreement"). On July 11, 2023, the registration statement on Form S-4 (File No. 333-267

NEW YORK, June 20, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from June 19, 2023 to July 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc.,

NEW YORK, May 19, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from May 19, 2023 to June 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc., a

NEW YORK, April 13, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from April 19, 2023 to May 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc.,

NEW YORK, March 17, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from March 19, 2023 to April 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc

NEW YORK, Feb. 17, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from February 19, 2023 to March 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such Extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, I

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

SC 13D - Estrella Immunopharma, Inc. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)